Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositisMichael O. Harris‐Love, Lisa G. Rider, Joseph A. Shrader et al.|Lara D. Veeken|2008Cited by 132
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisAdam Schiffenbauer, Mark F. Gourley, Megha Garg et al.|Seminars in Arthritis and Rheumatism|2017Cited by 70
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 studyNuria Carrillo, William A. Gahl, Bradley Class et al.|Genetics in Medicine|2021Cited by 55
Bayesian model of disease progression in GNE myopathyMelanie Quintana, Nuria Carrillo, Joseph A. Shrader et al.|Statistics in Medicine|2018Cited by 25